UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2005, Volume 366, Issue 9503, pp. 2087 - 2106
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Breast Neoplasms - surgery | Humans | Middle Aged | Probability | Cause of Death | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - radiotherapy | Time Factors | Breast Neoplasms - mortality | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Evaluation | Complications and side effects | Care and treatment | Patient outcomes | Breast cancer | Radiotherapy | Cancer | Relapse | Surgery | Breast | Health aspects | Risk factors | Diseases | Therapy | Side effects | Mortality | Radiology | Health risk assessment | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 27 - 39
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Risk Factors | Neoplasm Recurrence, Local | Treatment Outcome | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Disease Progression | Randomized Controlled Trials as Topic | Neoadjuvant Therapy - mortality | Neoplasm Metastasis | Time Factors | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Mastectomy, Segmental | Neoadjuvant Therapy - adverse effects | Adult | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Neoplasm Staging | Lumpectomy | Medical research | Anthracyclines | Patient outcomes | Mortality | Analysis | Adjuvant treatment | Medicine, Experimental | Breast cancer | Rankings | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2005, Volume 365, Issue 9472, pp. 1687 - 1717
UMCG Approved | TAMOXIFEN | DEATHS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Ovariectomy | Humans | Middle Aged | Neoplasm Recurrence, Local | Survival Rate | Receptors, Estrogen - analysis | Breast Neoplasms - drug therapy | Cause of Death | Randomized Controlled Trials as Topic | Breast Neoplasms - therapy | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Ovary - drug effects | Aged | Anthracyclines - therapeutic use | Chemotherapy, Adjuvant | Chemotherapy | Breast cancer | Diagnosis | Research | Drug therapy | Health aspects | Cancer | Clinical trials | Prescription drugs | Hormone replacement therapy | Mortality | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9793, pp. 771 - 784
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Miscellaneous | Biological and medical sciences | Medical sciences | Tumors | Receptors, Estrogen - metabolism | Neoplasm Recurrence, Local - prevention & control | Humans | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Randomized Controlled Trials as Topic | Receptors, Progesterone - metabolism | Antineoplastic Agents, Hormonal - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Neoplasms, Second Primary - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Patient outcomes | Breast cancer | Research | Diagnosis | Tamoxifen | Drug therapy | Health aspects | Chemotherapy | Compliance | Womens health | Mortality | Endocrine therapy | Data collection | Stratigraphy | Cancer therapies | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Space science reviews, ISSN 0038-6308, 4/2008, Volume 136, Issue 1, pp. 67 - 115
Solar corona | Astrophysics | Coronal loops | Coronal mass ejections | Heliospheric imager | Stereo | Physics | XUV heliograph | Heliosphere | Extraterrestrial Physics, Space Sciences | Planetology | Space Exploration and Astronautics | Lyot coronagraph | Physical Sciences | Astronomy & Astrophysics | Science & Technology | Investigations | Research institutes | Telescopes | Solar physics | Corona | Space exploration | Spacecraft | Optics
Journal Article